JAMES HYATT: Open Payments
NPI 1891878427 · RACELAND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,615 in 31 payments from 6 companies in 2025. Trend: 2023 $530 · 2024 $772 · 2025 $4,615
Honoraria: $2,600Food & beverage: $1,132Travel & lodging: $883
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 16 | $4,187 |
| Indivior Inc. | 6 | $248 |
| Alkermes, Inc. | 5 | $82 |
| Neurocrine BioSciences, Inc. | 2 | $40 |
| Janssen Pharmaceuticals, Inc | 1 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
Products named: BRIXADI, SUBLOCADE, VIVITROL, INGREZZA, INVEGA, TRINTELLIX, ARISTADA.
Industry payments across LA — which companies pay providers there.
